SBIO.L vs. ^GSPC
SBIO.L (Invesco Nasdaq Biotech UCITS ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD, while ^GSPC (S&P 500 Index) is an index. Over the past 10 years, SBIO.L returned 7.49%/yr vs 13.65%/yr for ^GSPC. At a 0.35 correlation, their price movements are largely independent.
Performance
SBIO.L vs. ^GSPC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO.L achieves a 4.34% return, which is significantly lower than ^GSPC's 10.79% return. Over the past 10 years, SBIO.L has underperformed ^GSPC with an annualized return of 7.49%, while ^GSPC has yielded a comparatively higher 13.65% annualized return.
SBIO.L
- 1D
- 3.10%
- 1M
- 0.91%
- YTD
- 4.34%
- 6M
- 2.82%
- 1Y
- 41.33%
- 3Y*
- 12.99%
- 5Y*
- 4.66%
- 10Y*
- 7.49%
^GSPC
- 1D
- 0.41%
- 1M
- 4.48%
- YTD
- 10.79%
- 6M
- 10.60%
- 1Y
- 27.02%
- 3Y*
- 21.07%
- 5Y*
- 12.39%
- 10Y*
- 13.65%
SBIO.L vs. ^GSPC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 4.34% | 32.89% | -2.00% | 6.14% | -11.85% | -0.49% | 27.35% | 25.54% | -11.34% | 21.45% |
^GSPC S&P 500 Index | 10.79% | 16.39% | 23.31% | 24.23% | -19.44% | 26.89% | 16.26% | 28.88% | -6.24% | 19.42% |
Correlation
The correlation between SBIO.L and ^GSPC is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Nov 10, 2014 | 0.35 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO.L vs. ^GSPC — Risk / Return Rank
SBIO.L
^GSPC
SBIO.L vs. ^GSPC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and S&P 500 Index (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO.L | ^GSPC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | -0.12 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.41 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 5.38 | 2.98 | +2.40 |
| Martin ratioReturn relative to average drawdown | 16.56 | 13.78 | +2.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SBIO.L | ^GSPC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.09 | 2.28 | -0.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 0.74 | -0.52 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | 0.76 | -0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.47 | -0.21 |
Drawdowns
SBIO.L vs. ^GSPC - Drawdown Comparison
The maximum SBIO.L drawdown since its inception was -39.44%, smaller than the maximum ^GSPC drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for SBIO.L and ^GSPC.
Loading charts...
Drawdown Indicators
| SBIO.L | ^GSPC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.44% | -56.78% | +17.34% |
Max Drawdown (1Y)Largest decline over 1 year | -7.64% | -9.10% | +1.46% |
Max Drawdown (3Y)Largest decline over 3 years | -26.88% | -18.90% | -7.98% |
Max Drawdown (5Y)Largest decline over 5 years | -38.33% | -25.43% | -12.90% |
Max Drawdown (10Y)Largest decline over 10 years | -38.33% | -33.92% | -4.41% |
Current DrawdownCurrent decline from peak | -2.84% | -0.33% | -2.51% |
Average DrawdownAverage peak-to-trough decline | -16.83% | -10.72% | -6.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.49% | 1.97% | +0.52% |
Volatility
SBIO.L vs. ^GSPC - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a higher volatility of 6.55% compared to S&P 500 Index (^GSPC) at 2.88%. This indicates that SBIO.L's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO.L | ^GSPC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.55% | 2.88% | +3.67% |
Volatility (6M)Calculated over the trailing 6-month period | 15.27% | 9.00% | +6.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.67% | 11.89% | +7.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.21% | 16.90% | +4.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.23% | 18.06% | +4.17% |
Frequently Asked Questions
SBIO.L and ^GSPC have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for SBIO.L and ^GSPC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer